Supernus [SUPN] vs Alkermes plc [ALKS] Detailed Stock Comparison
Supernus
Alkermes plc
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Supernus wins in 5 metrics, Alkermes plc wins in 14 metrics, with 0 ties. Alkermes plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Supernus | Alkermes plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 41.54 | 14.95 | Alkermes plc |
| Price-to-Book Ratio | 2.52 | 3.14 | Supernus |
| Debt-to-Equity Ratio | 2.99 | 4.47 | Supernus |
| PEG Ratio | 3.74 | -8.07 | Alkermes plc |
| EV/EBITDA | 16.78 | 10.33 | Alkermes plc |
| Profit Margin (TTM) | 9.70% | 23.15% | Alkermes plc |
| Operating Margin (TTM) | 6.73% | 23.80% | Alkermes plc |
| EBITDA Margin (TTM) | 6.73% | 23.80% | Alkermes plc |
| Return on Equity | 6.38% | 23.94% | Alkermes plc |
| Return on Assets (TTM) | 2.39% | 10.49% | Alkermes plc |
| Free Cash Flow (TTM) | $171.23M | $405.64M | Alkermes plc |
| 1-Year Return | 50.03% | 8.54% | Supernus |
| Price-to-Sales Ratio (TTM) | 4.03 | 3.40 | Alkermes plc |
| Enterprise Value | $2.22B | $4.17B | Alkermes plc |
| EV/Revenue Ratio | 3.34 | 2.77 | Alkermes plc |
| Gross Profit Margin (TTM) | 89.83% | 87.34% | Supernus |
| Revenue per Share (TTM) | $12 | $9 | Supernus |
| Earnings per Share (Diluted) | $1.15 | $2.07 | Alkermes plc |
| Beta (Stock Volatility) | 0.78 | 0.49 | Alkermes plc |
Supernus vs Alkermes plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Supernus | -1.03% | 3.23% | 7.56% | 51.55% | 55.89% | 35.90% |
| Alkermes plc | -0.54% | 0.38% | 12.68% | 4.67% | 8.92% | 9.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Supernus | 50.03% | 52.53% | 142.82% | 203.56% | 729.31% | 729.31% |
| Alkermes plc | 8.54% | 38.73% | 83.19% | -48.83% | 112.03% | 96.37% |
News Based Sentiment: Supernus vs Alkermes plc
Supernus
News based Sentiment: MIXED
October presented a mixed bag for Supernus, with strong analyst upgrades and a rising stock price fueled by Onapgo's success, offset by substantial insider selling. The Sage Therapeutics acquisition adds another layer of complexity, promising future synergies but requiring careful monitoring. This combination of factors makes October a significant month for the company's investment narrative.
Alkermes plc
News based Sentiment: POSITIVE
October brought a wave of positive analyst coverage and valuation assessments for Alkermes, suggesting the stock is currently undervalued and poised for potential growth. While technical indicators remain mixed, the overall narrative is increasingly optimistic, driven by anticipated earnings beats and upcoming clinical trial data.
Performance & Financial Health Analysis: Supernus vs Alkermes plc
| Metric | SUPN | ALKS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.69B | $5.11B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 575,185 | 1,713,950 |
| 90 Day Avg. Volume | 641,835 | 2,063,577 |
| Last Close | $49.00 | $31.21 |
| 52 Week Range | $29.16 - $51.78 | $25.17 - $36.45 |
| % from 52W High | -5.37% | -14.38% |
| All-Time High | $61.25 (Jun 25, 2018) | $98.50 (Feb 28, 2000) |
| % from All-Time High | -20.00% | -68.31% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | -0.02% |
| Quarterly Earnings Growth | 0.13% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.23% |
| Operating Margin (TTM) | 0.07% | 0.24% |
| Return on Equity (TTM) | 0.06% | 0.24% |
| Debt to Equity (MRQ) | 2.99 | 4.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $18.96 | $9.84 |
| Cash per Share (MRQ) | $9.32 | $6.15 |
| Operating Cash Flow (TTM) | $187.06M | $521.00M |
| Levered Free Cash Flow (TTM) | $150.12M | $345.67M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Supernus vs Alkermes plc
| Metric | SUPN | ALKS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 41.54 | 14.95 |
| Forward P/E | 25.28 | 15.40 |
| PEG Ratio | 3.74 | -8.07 |
| Price to Sales (TTM) | 4.03 | 3.40 |
| Price to Book (MRQ) | 2.52 | 3.14 |
| Market Capitalization | ||
| Market Capitalization | $2.69B | $5.11B |
| Enterprise Value | $2.22B | $4.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.34 | 2.77 |
| Enterprise to EBITDA | 16.78 | 10.33 |
| Risk & Other Metrics | ||
| Beta | 0.78 | 0.49 |
| Book Value per Share (MRQ) | $18.96 | $9.84 |
Financial Statements Comparison: Supernus vs Alkermes plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SUPN | ALKS |
|---|---|---|
| Revenue/Sales | $149.82M | $306.51M |
| Cost of Goods Sold | $15.76M | $49.20M |
| Gross Profit | $134.06M | $257.31M |
| Research & Development | $26.93M | $71.82M |
| Operating Income (EBIT) | $-2.60M | $13.79M |
| EBITDA | $25.45M | $32.91M |
| Pre-Tax Income | $-5.83M | $25.49M |
| Income Tax | $6.00M | $3.03M |
| Net Income (Profit) | $-11.83M | $22.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SUPN | ALKS |
|---|---|---|
| Cash & Equivalents | $115.85M | $399.81M |
| Total Current Assets | $687.58M | $1.48B |
| Total Current Liabilities | $281.77M | $443.73M |
| Long-Term Debt | $26.37M | $67.81M |
| Total Shareholders Equity | $1.03B | $1.51B |
| Retained Earnings | $544.60M | $-953.99M |
| Property, Plant & Equipment | $0 | $82.41M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SUPN | ALKS |
|---|---|---|
| Operating Cash Flow | $22.33M | $122.31M |
| Capital Expenditures | $-327,000 | $-8.40M |
| Free Cash Flow | $30.27M | $88.70M |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUPN | ALKS |
|---|---|---|
| Shares Short | 5.02M | 15.06M |
| Short Ratio | 7.69 | 7.58 |
| Short % of Float | 0.13% | 0.13% |
| Average Daily Volume (10 Day) | 575,185 | 1,713,950 |
| Average Daily Volume (90 Day) | 641,835 | 2,063,577 |
| Shares Outstanding | 55.74M | 162.18M |
| Float Shares | 48.80M | 162.42M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 1.09% | 1.05% |
Dividend Analysis & Yield Comparison: Supernus vs Alkermes plc
| Metric | SUPN | ALKS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |